Methylpiperazine

Methylpiperazine

SCHEMBL6016489

CN1CCNCC1.COc1ccccc1-c1nc(N2CCN(C)CC2)ncc1C(=O)O

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 1/20 0.44
CYP1A2 P05177 8/20 0.43
CYP3A4 P08684 5/20 0.43
ALDH1A1 P00352 5/20 0.43
HSD17B10 Q99714 4/20 0.43
CYP2C19 P33261 3/20 0.43
USP2 O75604 3/20 0.43
CYP2D6 P10635 2/20 0.43
MEN1 O00255 1/20 0.43
ALOX15 P16050 1/20 0.43
KMT2A Q03164 1/20 0.43
TSHR P16473 2/20 0.42
HTR7 P34969 3/20 0.41
HTR2B P41595 2/20 0.41
CDK1 P06493 1/20 0.40
CDK4 P11802 1/20 0.40
CCND1 P24385 1/20 0.40
CDK2 P24941 1/20 0.40
CASP1 P29466 4/20 0.40
CASP7 P55210 4/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4119303 0.94 CYP1A2 (0.48) TACR1CYP1A2CYP3A4ALDH1A1HSD17B10
SCHEMBL4126532 0.93 HTR7 (0.48) CYP1A2CYP3A4ALDH1A1HSD17B10CYP2C19
Piperazine SCHEMBL6016330 0.92 HTR7 (0.47) CYP1A2CYP3A4ALDH1A1HSD17B10CYP2C19
Methylpiperazine SCHEMBL6016369 0.87 TACR1 (0.54) TACR1CYP1A2CYP3A4ALDH1A1HSD17B10
Methylpiperazine SCHEMBL6016457 0.86 TACR1 (0.43) TACR1CYP1A2CYP3A4ALDH1A1HSD17B10
Methylpiperazine SCHEMBL6016376 0.86 TSHR (0.46) TACR1CYP1A2CYP3A4ALDH1A1HSD17B10
Methylpiperazine SCHEMBL6016601 0.86 HRH4 (0.44) TACR1CYP1A2CYP3A4ALDH1A1HSD17B10
Methylpiperazine SCHEMBL6862208 0.85 HTR7 (0.47) TACR1CYP1A2CYP3A4ALDH1A1HSD17B10
Methylpiperazine SCHEMBL6876077 0.85 HTT (0.41) CYP1A2CYP3A4ALDH1A1HSD17B10CYP2C19
Methylpiperazine SCHEMBL6016296 0.85 TACR1 (0.43) TACR1CYP1A2CYP3A4ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1187815-B1 4-PHENYL-PYRIMIDINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2006-02-08 EP disclosed
EP-1187815-A1 4-PHENYL-PYRIMIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2002-03-20 EP disclosed
US-6274588-B1 NEUROKININ OR SUBSTANCE P ANTAGONISTS; CENTRAL NERVOUS SYSTEM AND PSYCHOLOGICAL DISORDES; ANTIDEPRESSANTS, ANXIOLYTIC AGENTS HOFFMANN-LA ROCHE INC. 2001-08-14 US disclosed
WO-2000073279-A1 4-PHENYL-PYRIMIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2000-12-07 WO disclosed